COVID-19 drug: Pxlovid may be available in Canadian pharmacies soon

• Facebook
• Twitter
• Reddit
• Tumblr
• LinkedIn
• Pinterest
• RSS Feed
• Link

COVID-19 drug: Pxlovid may be available in Canadian pharmacies soon

• Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
• Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
• FDA has mandated a top-level black box warning for all marketed CAR-T therapies
• Can people with high blood pressure eat peanuts?
• What is the difference between dopamine and dobutamine?
• How long can the patient live after heart stent surgery?

COVID-19 drug: Pxlovid may be available in Canadian pharmacies soon.

Good news is coming! Pfizer’s COVID-19 drug Paxlovid will be officially launched in Canada!  People are finally looking forward to the day when we finally defeat the COVID-19 virus. This drug Paxlovid will be available at pharmacies and take it at home, just like common cold medicine.

The biggest advantage of this medicine is that it has the same effect on all mutated new coronaviruses! That is to say, it can solve the most threatening variant omicron at present.

Health Canada’s chief medical adviser, Dr. Supriya Sharma, said Thursday that the agency is in the final stages of a review of Pfizer’s antiviral treatment.

Pfizer submitted clinical data for its drug Paxlovid on December 1, 2021.

In a statement to CTVNews.ca, Sharma said: “We are in the final stages of our review. I can’t commit to a specific time frame, but we will probably make a decision within the next week to 10 days . “

In late December, the U.S. Food and Drug Administration (FDA) granted emergency use authorizations to drugs from Pfizer and Merck.

In December last year, the U.S. FDA (Food and Drug Administration) officially announced that the COVID-19 specific drug was listed on Walmart. And first supply high-risk groups (65 years and older). Pfizer announced that once the FDA passed, they would publish the patents, allowing countries around the world to manufacture for free.

Secondary data released by the FDA are as follows:

• Safety: 20,000 people took it in the trial, no deaths, and 19.8% had only mild reactions
• Course of treatment: two times a day, three capsules each time, take for five days
• Severe illness effect: 1. Start taking this medicine three days after the onset of the disease, and 89% of them are cured after taking the medicine for 5 days;
• After 5 days of onset, start taking this medicine, 88% recover after 5 days, and the rest are completely recovered after two courses of treatment.

The pill is designed to block the activity of an enzyme necessary for a virus in SARS-CoV-2 to replicate itself and slow the breakdown of the pill’s components to help fight the virus longer, the drug company said in a release.

Part of the drug uses ritonavir, an existing drug that has previously been used in combination with other antiviral drugs.

Provinces and territories have been calling on the federal government to speed up the approval process as the highly contagious variant of Omicron emerges.

However, the Ministry of Health has made clear the steps that need to be met to approve a drug in Canada and will not change due to political pressure.

Health Canada spokesman Mark Johnson told CTVNews: “Health Canada will only approve the use of antiviral therapy if an independent, thorough scientific review of all data contained in the submission shows that the benefits of antiviral therapy outweigh the potential risks. virus treatment.”

COVID-19 drug: Pxlovid may be available in Canadian pharmacies soon

(source:internet, reference only)

Disclaimer of medicaltrend.org

Important Note: The information provided is for informational purposes only and should not be considered as medical advice.